Decreased miR-150 in obesity-associated type 2 diabetic mice increases intraocular inflammation and exacerbates retinal dysfunction

INTRODUCTION: Diabetic retinopathy (DR) is the leading cause of blindness among the working population in the USA. Current therapies, including anti-vascular endothelial growth factor treatments, cannot completely reverse the visual defects induced by DR. MicroRNA-150 (miR-150) is a regulator that s...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Fei, Chapman, Samantha, Pham, Dylan Luc, Ko, Michael Lee, Zhou, Beiyan, Ko, Gladys Y-P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Pathophysiology/Complications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7517560/
https://www.ncbi.nlm.nih.gov/pubmed/32973073
http://dx.doi.org/10.1136/bmjdrc-2020-001446

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7517560/
https://www.ncbi.nlm.nih.gov/pubmed/32973073
http://dx.doi.org/10.1136/bmjdrc-2020-001446

Ejemplares similares